1
|
Mohsin AS, Jamiruddin MR, Peyal MMK, Sharmin S, Ahmed A, Puspita AH, Sharfuddin A, Malik A, Hasib A, Suchona SA, Chowdhury AM, Kabir ER. Design optimization and validation of UV-C illumination chamber for filtering facepiece respirators. Heliyon 2024; 10:e26348. [PMID: 38439842 PMCID: PMC10909644 DOI: 10.1016/j.heliyon.2024.e26348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Revised: 09/10/2023] [Accepted: 02/12/2024] [Indexed: 03/06/2024] Open
Abstract
In this study, we constructed an UV-C illumination chamber using commercially available germicidal lamps and other locally available low-cost components for general-purpose biological decontamination purposes. The illumination chamber provides uniform illumination of around 1 J/cm2 in under 5 min across the chamber. The control mechanism was developed to automate the on/off process and make it more secure minimizing health and other electrical safety. To validate the decontamination efficacy of the UV-C Illumination Chamber we performed the Geobacillus spore strip culture assay. Additionally, we performed the viral load measurement by identifying the COVID-19-specific N-gene and ORF1 gene on surgical masks. The gold standard RT-qPCR measurement was performed to detect and quantify the COVID-19-specific gene on the mask sample. The biochemical assay was conducted on the control and test group to identify the presence of different types of bacteria, and fungi before and after exposure under the illumination chamber. The findings of our study revealed satisfactory decontamination efficacy test results. Therefore, it could be an excellent device in healthcare settings as a disinfection tool for biological decontamination such as SAR-CoV-2 virus, personal protection equipment (PPE), (including n95, k95 respirators, and surgical masks), and other common pathogens.
Collapse
Affiliation(s)
- Abu S.M. Mohsin
- Department of Electrical and Electronics Engineering, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - Mohd. Raeed Jamiruddin
- School of Pharmacy, Brac University, 66 Mohakhali, Dhaka, Bangladesh
- Gonoshasthaya-RNA Molecular Diagnostic and Research Center, Dhaka, Bangladesh
| | - Md Mahmudul Kabir Peyal
- Department of Electrical and Electronics Engineering, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - Shahana Sharmin
- School of Pharmacy, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - Ashfaq Ahmed
- School of Pharmacy, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - Afrin Hossain Puspita
- Department of Electrical and Electronics Engineering, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - A.A.M. Sharfuddin
- School of Pharmacy, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - Afrida Malik
- Department of Electrical and Electronics Engineering, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - Al Hasib
- School of Pharmacy, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | | | - Arshad M. Chowdhury
- Department of Electrical and Electronics Engineering, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| | - Eva Rahman Kabir
- School of Pharmacy, Brac University, 66 Mohakhali, Dhaka, Bangladesh
| |
Collapse
|
2
|
Farré R, Gozal D, Nguyen VN, Pearce JM, Dinh-Xuan AT. Open-Source Hardware May Address the Shortage in Medical Devices for Patients with Low-Income and Chronic Respiratory Diseases in Low-Resource Countries. J Pers Med 2022; 12:jpm12091498. [PMID: 36143283 PMCID: PMC9502622 DOI: 10.3390/jpm12091498] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2022] [Revised: 09/04/2022] [Accepted: 09/10/2022] [Indexed: 01/09/2023] Open
Abstract
Respiratory diseases pose an increasing socio-economic burden worldwide given their high prevalence and their elevated morbidity and mortality. Medical devices play an important role in managing acute and chronic respiratory failure, including diagnosis, monitoring, and providing artificial ventilation. Current commercially available respiratory devices are very effective but, given their cost, are unaffordable for most patients in low- and middle-income countries (LMICs). Herein, we focus on a relatively new design option—the open-source hardware approach—that, if implemented, will contribute to providing low-cost respiratory medical devices for many patients in LMICs, particularly those without full medical insurance coverage. Open source reflects a set of approaches to conceive and distribute the comprehensive technical information required for building devices. The open-source approach enables free and unrestricted use of the know-how to replicate and manufacture the device or modify its design for improvements or adaptation to different clinical settings or personalized treatments. We describe recent examples of open-source devices for diagnosis/monitoring (measuring inspiratory/expiratory pressures or flow and volume in mechanical ventilators) and for therapy (non-invasive ventilators for adults and continuous positive airway pressure support for infants) that enable building simple, low-cost (hence, affordable), and high-performance solutions for patients in LMICs. Finally, we argue that the common practice of approving clinical trials by the local hospital ethics board can be expanded to ensure patient safety by reviewing, inspecting, and approving open hardware for medical application to maximize the innovation and deployment rate of medical technologies.
Collapse
Affiliation(s)
- Ramon Farré
- Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain
- CIBER de Enfermedades Respiratorias, 28029 Madrid, Spain
- Institut Investigacions Biomèdiques August Pi Sunyer, 08036 Barcelona, Spain
- Correspondence:
| | - David Gozal
- Department of Child Health, The University of Missouri School of Medicine, Columbia, MO 65201, USA
| | - Viet-Nhung Nguyen
- National Tuberculosis Program, 463 Hoang Hoa Tham, Vinh Phu, Ba Dinh, Hanoi 118000, Vietnam
| | - Joshua M. Pearce
- Department of Electrical & Computer Engineering, Ivey Business School, Western University, London, ON N6A 5B9, Canada
| | - Anh Tuan Dinh-Xuan
- Service de Physiologie-Explorations Fonctionnelles, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), 75014 Paris, France
| |
Collapse
|
3
|
Harfoot R, Yung DBY, Anderson WA, Wild CEK, Coetzee N, Hernández LC, Lawley B, Pletzer D, Derraik JGB, Anderson YC, Quiñones-Mateu ME. Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators. Pathogens 2022; 11:83. [PMID: 35056031 PMCID: PMC8780977 DOI: 10.3390/pathogens11010083] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2021] [Revised: 01/06/2022] [Accepted: 01/08/2022] [Indexed: 02/01/2023] Open
Abstract
The arrival of SARS-CoV-2 to Aotearoa/New Zealand in February 2020 triggered a massive response at multiple levels. Procurement and sustainability of medical supplies to hospitals and clinics during the then upcoming COVID-19 pandemic was one of the top priorities. Continuing access to new personal protective equipment (PPE) was not guaranteed; thus, disinfecting and reusing PPE was considered as a potential alternative. Here, we describe part of a local program intended to test and implement a system to disinfect PPE for potential reuse in New Zealand. We used filtering facepiece respirator (FFR) coupons inoculated with SARS-CoV-2 or clinically relevant multidrug-resistant pathogens (Acinetobacter baumannii Ab5075, methicillin-resistant Staphylococcus aureus USA300 LAC and cystic-fibrosis isolate Pseudomonas aeruginosa LESB58), to evaluate the potential use of ultraviolet-C germicidal irradiation (UV-C) or dry heat treatment to disinfect PPE. An applied UV-C dose of 1000 mJ/cm2 was sufficient to completely inactivate high doses of SARS-CoV-2; however, irregularities in the FFR coupons hindered the efficacy of UV-C to fully inactivate the virus, even at higher UV-C doses (2000 mJ/cm2). Conversely, incubating contaminated FFR coupons at 65 °C for 30 min or 70 °C for 15 min, was sufficient to block SARS-CoV-2 replication, even in the presence of mucin or a soil load (mimicking salivary or respiratory secretions, respectively). Dry heat (90 min at 75 °C to 80 °C) effectively killed 106 planktonic bacteria; however, even extending the incubation time up to two hours at 80 °C did not completely kill bacteria when grown in colony biofilms. Importantly, we also showed that FFR material can harbor replication-competent SARS-CoV-2 for up to 35 days at room temperature in the presence of a soil load. We are currently using these findings to optimize and establish a robust process for decontaminating, reusing, and reducing wastage of PPE in New Zealand.
Collapse
Affiliation(s)
- Rhodri Harfoot
- Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand; (R.H.); (D.B.Y.Y.); (L.C.H.); (B.L.); (D.P.)
| | - Deborah B. Y. Yung
- Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand; (R.H.); (D.B.Y.Y.); (L.C.H.); (B.L.); (D.P.)
| | - William A. Anderson
- Department of Chemical Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada;
| | - Cervantée E. K. Wild
- Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand; (C.E.K.W.); (N.C.); (J.G.B.D.)
| | - Nicolene Coetzee
- Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand; (C.E.K.W.); (N.C.); (J.G.B.D.)
| | - Leonor C. Hernández
- Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand; (R.H.); (D.B.Y.Y.); (L.C.H.); (B.L.); (D.P.)
| | - Blair Lawley
- Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand; (R.H.); (D.B.Y.Y.); (L.C.H.); (B.L.); (D.P.)
| | - Daniel Pletzer
- Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand; (R.H.); (D.B.Y.Y.); (L.C.H.); (B.L.); (D.P.)
| | - José G. B. Derraik
- Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand; (C.E.K.W.); (N.C.); (J.G.B.D.)
| | - Yvonne C. Anderson
- Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand; (C.E.K.W.); (N.C.); (J.G.B.D.)
| | - Miguel E. Quiñones-Mateu
- Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand; (R.H.); (D.B.Y.Y.); (L.C.H.); (B.L.); (D.P.)
- Webster Centre for Infectious Diseases, University of Otago, Dunedin 9016, New Zealand
| |
Collapse
|